Nerviano Medical Sciences - Product Pipeline Review - 2014

  • July 2014
  • -
  • Global Markets Direct
  • -
  • 52 pages

Nerviano Medical Sciences - Product Pipeline Review - 2014

Summary

Global Markets Direct’s, ‘Nerviano Medical Sciences - Product Pipeline Review - 2014’, provides an overview of the Nerviano Medical Sciences ’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Nerviano Medical Sciences ’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Nerviano Medical Sciences including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Nerviano Medical Sciences ’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Nerviano Medical Sciences ’s pipeline products

Reasons to buy

- Evaluate Nerviano Medical Sciences ’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Nerviano Medical Sciences in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Nerviano Medical Sciences ’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Nerviano Medical Sciences and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Nerviano Medical Sciences
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Nerviano Medical Sciences and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

Table Of Contents

Table of Contents
Table of Contents 2


Nerviano Medical Sciences Snapshot 6
Nerviano Medical Sciences Overview 6
Key Information 6
Key Facts 6
Nerviano Medical Sciences - Research and Development Overview 7
Key Therapeutic Areas 7
Nerviano Medical Sciences - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
Pipeline Products - Out-Licensed Products 12
Out-Licensed Products/Combination Treatment Modalities 13
Nerviano Medical Sciences - Pipeline Products Glance 14
Nerviano Medical Sciences - Clinical Stage Pipeline Products 14
Phase II Products/Combination Treatment Modalities 14
Phase I Products/Combination Treatment Modalities 15
Nerviano Medical Sciences - Early Stage Pipeline Products 16
Preclinical Products/Combination Treatment Modalities 16
Discovery Products/Combination Treatment Modalities 17
Nerviano Medical Sciences - Drug Profiles 18
danusertib 18
Product Description 18
Mechanism of Action 18
RandD Progress 18
milciclib 20
Product Description 20
Mechanism of Action 20
RandD Progress 20
nemorubicin 22
Product Description 22
Mechanism of Action 22
RandD Progress 22
NMS-E628 23
Product Description 23
Mechanism of Action 23
RandD Progress 23
NMS-1116354 24
Product Description 24
Mechanism of Action 24
RandD Progress 24
NMS-1286937 25
Product Description 25
Mechanism of Action 25
RandD Progress 25
NMS-616 26
Product Description 26
Mechanism of Action 26
RandD Progress 26
NMS-P118 27
Product Description 27
Mechanism of Action 27
RandD Progress 27
NMS-P153 28
Product Description 28
Mechanism of Action 28
RandD Progress 28
NMS-P285 29
Product Description 29
Mechanism of Action 29
RandD Progress 29
NMS-P506 30
Product Description 30
Mechanism of Action 30
RandD Progress 30
NMS-P626 31
Product Description 31
Mechanism of Action 31
RandD Progress 31
NMS-P648 32
Product Description 32
Mechanism of Action 32
RandD Progress 32
NMS-P715 33
Product Description 33
Mechanism of Action 33
RandD Progress 33
NMS-P914 34
Product Description 34
Mechanism of Action 34
RandD Progress 34
NMS-P948 35
Product Description 35
Mechanism of Action 35
RandD Progress 35
NMSE-973 36
Product Description 36
Mechanism of Action 36
RandD Progress 36
PHA-793887 37
Product Description 37
Mechanism of Action 37
RandD Progress 37
Small Molecule to Inhibit RET for Oncology 38
Product Description 38
Mechanism of Action 38
RandD Progress 38
NMS-873 39
Product Description 39
Mechanism of Action 39
RandD Progress 39
Small Molecule to Inhibit Pim Kinase for Oncology 40
Product Description 40
Mechanism of Action 40
RandD Progress 40
Nerviano Medical Sciences - Pipeline Analysis 41
Nerviano Medical Sciences - Pipeline Products by Target 41
Nerviano Medical Sciences - Pipeline Products by Route of Administration 43
Nerviano Medical Sciences - Pipeline Products by Molecule Type 44
Nerviano Medical Sciences - Pipeline Products by Mechanism of Action 45
Nerviano Medical Sciences - Recent Pipeline Updates 47
Nerviano Medical Sciences - Dormant Projects 49
Nerviano Medical Sciences - Locations And Subsidiaries 50
Head Office 50
Appendix 51
Methodology 51
Coverage 51
Secondary Research 51
Primary Research 51
Expert Panel Validation 51
Contact Us 52
Disclaimer 52

List of Tables

Nerviano Medical Sciences, Key Information 6
Nerviano Medical Sciences, Key Facts 6
Nerviano Medical Sciences - Pipeline by Indication, 2014 8
Nerviano Medical Sciences - Pipeline by Stage of Development, 2014 10
Nerviano Medical Sciences - Monotherapy Products in Pipeline, 2014 11
Nerviano Medical Sciences - Out-Licensed Products in Pipeline, 2014 12
Nerviano Medical Sciences - Out-Licensed Products/ Combination Treatment Modalities, 2014 13
Nerviano Medical Sciences - Phase II, 2014 14
Nerviano Medical Sciences - Phase I, 2014 15
Nerviano Medical Sciences - Preclinical, 2014 16
Nerviano Medical Sciences - Discovery, 2014 17
Nerviano Medical Sciences - Pipeline by Target, 2014 42
Nerviano Medical Sciences - Pipeline by Route of Administration, 2014 43
Nerviano Medical Sciences - Pipeline by Molecule Type, 2014 44
Nerviano Medical Sciences - Pipeline Products by Mechanism of Action, 2014 46
Nerviano Medical Sciences - Recent Pipeline Updates, 2014 47
Nerviano Medical Sciences - Dormant Developmental Projects,2014 49

List of Figures

Nerviano Medical Sciences - Pipeline by Top 10 Indication, 2014 8
Nerviano Medical Sciences - Pipeline by Stage of Development, 2014 10
Nerviano Medical Sciences - Monotherapy Products in Pipeline, 2014 11
Nerviano Medical Sciences - Out-Licensed Products in Pipeline, 2014 12
Nerviano Medical Sciences - Pipeline by Top 10 Target, 2014 41
Nerviano Medical Sciences - Pipeline by Top 10 Route of Administration, 2014 43
Nerviano Medical Sciences - Pipeline by Top 10 Molecule Type, 2014 44
Nerviano Medical Sciences - Pipeline Products by Top 10 Mechanism of Action, 2014 45

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Clare

+1 339 368 6001

Purchase Reports From Reputable Market Research Publishers

Lipicard Technologies Limited - Product Pipeline Review - 2014

Lipicard Technologies Limited - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • June 2014
  • by Global Markets Direct

Lipicard Technologies Limited - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Lipicard Technologies Limited - Product Pipeline Review - 2014', provides an overview of the Lipicard ...

Aphios Corporation - Product Pipeline Review - 2014

Aphios Corporation - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • July 2014
  • by Global Markets Direct

Aphios Corporation - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Aphios Corporation - Product Pipeline Review - 2014', provides an overview of the Aphios Corporation's pharmaceutical ...

ViroStatics, srl - Product Pipeline Review - 2014

ViroStatics, srl - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • July 2014
  • by Global Markets Direct

ViroStatics, srl - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘ViroStatics, srl - Product Pipeline Review - 2014', provides an overview of the ViroStatics, srl's pharmaceutical research ...


6 Companies

Company Profiles


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.